Galapagos Says As Of Today's Date, The Board Has Received A Limited Number Of Non-binding Offers From Consortia, Predominantly Comprised Of Financial Investors, To Acquire The Cell Therapy Business.
Author: Benzinga Newsdesk | October 01, 2025 03:03pm